Cambridge, MA · Founded 2017 · Privately Held (backing)
Developer of a pharmacologic therapy designed to target orally dosed medicines, the key underlying neurobiological mechanisms that lead to airway obstruction. Apnimed is based in Cambridge, MA and was founded in 2017. It was valued at $434 million at its later-stage round in Mar 2026, the last priced event on record. It has raised $434 million across 8 recorded rounds; the latest was a $25 million early-stage round in Mar 2026.
These 7 firms already write checks for companies like Apnimed. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.